Effects of Mulligan Mobilization With and Without Sling Exercises in Non-specific Neck Pain
- Disease/Condition
- Neck Pain
- Drug/Device/Intervention
- Mulligan Mobilization and Sling Exercises
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Riphah International University
- Location
- Faisalābad, Pakistan
- Phase
- N/A
- Start date
- Mar 10, 2024
- End date
- Jul 30, 2024
- Enrollment
- 46 participants
Numerical Pain Rating Scale,Neck Disability Index,Universal Goniometer
Neck pain is one of the common musculoskeletal problems. People with neck pain can have
 difficulties with daily activities and be limited in work and social participation. Main
 symptoms of people with neck pain include pain, decreased range of motion (ROM), muscle
 weakness and dysfunction. Common neck pain causes include degenerative disc disease,
 herniated disc disease, cervical radiculopathies, myofascial pain syndrome and viral
 infections. Muscular strains, postural and ergonomics are also related to neck pain and
 whiplash injuries. The onset of pain may be insidious or may follow trauma, and it may be
 recurrent or persistent in nature. Ideally, the pain goes away in 1-3 weeks, but in some
 cases it persists and become chronic neck pain. The aim of this study is to compare the
 effects of mulligan mobilization with and without sling exercises on pain, and disability in
 non-specific neck pain. Non-specific neck pain reduces range of motion which may be linked to
 mechanical restriction between two or more vertebrae and muscular spasm.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06241014
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06241014 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Neck Pain. Target enrollment is 46 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.